Norodine 24, 40 mg/200 mg/ml, süstelahus
Norodine 24, 40 mg/200 mg/ml, süstelahus
Not authorised
- Trimethoprim
- Sulfadiazine
Product identification
Medicine name:
Norodine 24, 40 mg/200 mg/ml, süstelahus
Active substance:
- Trimethoprim
- Sulfadiazine
Target species:
-
Horse
-
Cattle
-
Pig
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Trimethoprim40.00milligram(s)1.00millilitre(s)
-
Sulfadiazine200.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intravenous use
-
Horse
-
Meat and offalno withdrawal periodHobune: mitte kasutada hobustel, kelle liha plaanitakse tarvitada inimtoiduks.
-
-
Cattle
-
Meat and offal12day
-
Milk60hour
-
-
Pig
-
Meat and offal15day
-
-
-
Intramuscular use
-
Cattle
-
Meat and offal12day
-
Milk60hour
-
-
Pig
-
Meat and offal15day
-
-
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01EW10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Manufacturing Limited
- Norbrook Laboratories Limited
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1055
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 25/01/2022
How useful was this page?: